|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VISTA MEDICAL TECHNOLOGIES INC, 10-Q, 2000-11-13 |
Next: VISTA MEDICAL TECHNOLOGIES INC, 10-Q, EX-27, 2000-11-13 |
<PAGE>
EXHIBIT 11.1
VISTA MEDICAL TECHNOLOGIES, INC.
STATEMENT REGARDING COMPUTATION OF PER SHARE DATA
<TABLE>
<CAPTION>
Three Months Ended September 30, Nine Months Ended September 30,
--------------------------------- ----------------------------------
2000 1999 2000 1999
----------- ------------ ------------ -------------
<S> <C> <C> <C> <C>
Net income (loss) $ (153,713) $ (2,376,185) $ (2,116,983) $ (8,334,655)
Weighted average common shares outstanding 19,525,347 13,655,734 17,454,598 13,565,711
----------- ------------ ------------ -------------
Shares used in basic and diluted loss per share 19,525,347 13,655,734 17,454,598 13,565,711
=========== ============ ============ =============
Basic and diluted loss per share $ (0.01) $ (0.17) $ (0.12) $ (0.61)
=========== ============ ============ =============
</TABLE>
|
|